Euro MPs keep up the pressure on trial data disclosure
This article was originally published in SRA
Executive Summary
Pharmaceutical companies hoping for some let-up in the drive for more clinical trial data disclosure will have found little comfort in the 20 March debate at the European Parliament's environment and public health committee (ENVI), when MEPs backed calls for trial data to be published when a new drug has been approved for marketing1,2.